Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing.

MLA

Rehman, Rahiya, et al. “Ustekinumab for Anti-Tumor Necrosis Factor Refractory Pediatric Ulcerative Colitis: A Promising Approach towards Endoscopic Healing.” Intestinal Research, vol. 22, no. 3, July 2024, pp. 351–56. EBSCOhost, https://doi.org/10.5217/ir.2023.00091.

APA

Rehman, R., Riaz, M. S., Esharif, D., Has, P., Herzlinger, M., Shapiro, J., & Subedi, S. (2024). Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing. Intestinal Research, 22(3), 351–356. https://doi.org/10.5217/ir.2023.00091

Chicago

Rehman, Rahiya, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, and Shova Subedi. 2024. “Ustekinumab for Anti-Tumor Necrosis Factor Refractory Pediatric Ulcerative Colitis: A Promising Approach towards Endoscopic Healing.” Intestinal Research 22 (3): 351–56. doi:10.5217/ir.2023.00091.